175 related articles for article (PubMed ID: 36867519)
1. Association between Early Venous Thromboembolism Prophylaxis, Bleeding Risk, and Venous Thromboembolism among Critically Ill Patients with Thrombocytopenia.
Pang B; Kearney L; Maccarone J; Zhang J; Kearney C; Sangani R; Shankar DA; Gillmeyer KR; Law AC; Bosch NA
Ann Am Thorac Soc; 2023 Jun; 20(6):917-920. PubMed ID: 36867519
[No Abstract] [Full Text] [Related]
2. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
[TBL] [Abstract][Full Text] [Related]
3. European guidelines on perioperative venous thromboembolism prophylaxis: Intensive care.
Duranteau J; Taccone FS; Verhamme P; Ageno W;
Eur J Anaesthesiol; 2018 Feb; 35(2):142-146. PubMed ID: 29112545
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Prophylactic Heparin Dosage Strategies and Risk Factors for Venous Thromboembolism in the Critically Ill Patient.
Reynolds PM; Van Matre ET; Wright GC; McQueen RB; Burnham EL; Ho PJM; Moss M; Vandivier RW; Kiser TH;
Pharmacotherapy; 2019 Mar; 39(3):232-241. PubMed ID: 30592541
[TBL] [Abstract][Full Text] [Related]
5. Venous Thromboembolism Prophylaxis in Low Body Weight Critically Ill Patients.
Knox H; Edwin SB; Giuliano C; Paxton RA
J Intensive Care Med; 2024 May; 39(5):493-498. PubMed ID: 38111295
[TBL] [Abstract][Full Text] [Related]
6. Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.
Di Nisio M; Porreca E
Drug Des Devel Ther; 2013; 7():973-80. PubMed ID: 24068866
[TBL] [Abstract][Full Text] [Related]
7. Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.
Wang TY; Honeycutt EF; Tapson VF; Moll S; Granger CB; Ohman EM
Am J Med; 2012 Dec; 125(12):1214-21. PubMed ID: 22939359
[TBL] [Abstract][Full Text] [Related]
8. Venous Thromboembolism Prophylaxis in Acute Medically Ill Patients: A Retrospective Cohort Study.
Gafter-Gvili A; Drozdinsky G; Zusman O; Kushnir S; Leibovici L
Am J Med; 2020 Dec; 133(12):1444-1452.e3. PubMed ID: 32445719
[TBL] [Abstract][Full Text] [Related]
9. Heparin-induced thrombocytopenia in critically ill patients.
Warkentin TE
Crit Care Clin; 2011 Oct; 27(4):805-23, v. PubMed ID: 22082515
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
11. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency.
Cook DJ; Douketis J; Arnold D; Crowther MA
Curr Opin Pulm Med; 2009 Sep; 15(5):455-62. PubMed ID: 19617833
[TBL] [Abstract][Full Text] [Related]
12. Thrombocytopenia and bleeding events in patients with venous thromboembolism.
Ito S; Inoko M; Yamashita Y; Morimoto T; Kimura T;
Eur J Intern Med; 2024 Apr; 122():132-134. PubMed ID: 38238133
[No Abstract] [Full Text] [Related]
13. Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years.
Tufano A; Brenner B
Semin Thromb Hemost; 2024 Feb; 50(1):96-103. PubMed ID: 37201536
[TBL] [Abstract][Full Text] [Related]
14. Safety of anticoagulation in the treatment of venous thromboembolism in patients with haematological malignancies and thrombocytopenia: Report of 5 cases and literature review.
Lim MS; Enjeti AK
Crit Rev Oncol Hematol; 2016 Sep; 105():92-9. PubMed ID: 27397486
[TBL] [Abstract][Full Text] [Related]
15. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
He Y; He H; Liu D; Long Y; Su L; Cheng W
Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of thromboembolism during therapy with asparaginase in adults with acute lymphoblastic leukaemia.
Rank CU; Lynggaard LS; Als-Nielsen B; Stock W; Toft N; Nielsen OJ; Frandsen TL; Tuckuviene R; Schmiegelow K
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013399. PubMed ID: 33038027
[TBL] [Abstract][Full Text] [Related]
17. Natural history of patients developing thrombocytopenia while receiving anticoagulant therapy for venous thromboembolism.
Di Micco P; Fontanella A; Falvo N; Bonithon-Kopp C; Decousus H; Riera-Mestre A; Monreal M;
Int Angiol; 2012 Feb; 31(1):92-5. PubMed ID: 22330631
[No Abstract] [Full Text] [Related]
18. Deep Vein Thrombosis in Intensive Care.
Boddi M; Peris A
Adv Exp Med Biol; 2017; 906():167-181. PubMed ID: 27628009
[TBL] [Abstract][Full Text] [Related]
19. Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients.
Obi AT; Tignanelli CJ; Jacobs BN; Arya S; Park PK; Wakefield TW; Henke PK; Napolitano LM
J Vasc Surg Venous Lymphat Disord; 2019 May; 7(3):317-324. PubMed ID: 30477976
[TBL] [Abstract][Full Text] [Related]
20. Systemic bleeding in a patient with enoxaparin-induced thrombocytopenia.
Famularo G; Gasbarrone L; Minisola G; De Simone C
Am J Emerg Med; 2009 Jul; 27(6):756.e1-2. PubMed ID: 19751647
[No Abstract] [Full Text] [Related]
[Next] [New Search]
